Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 1.767
Filter
2.
East Mediterr Health J ; 29(4): 232-235, 2023 Apr 27.
Article in English | MEDLINE | ID: covidwho-20245497
3.
Cien Saude Colet ; 26(11): 5589-5598, 2021 Nov.
Article in Portuguese, English | MEDLINE | ID: covidwho-20242971

ABSTRACT

The 16th National Health Conference illustrated the interest of health councils to intervene in public policies in order to guarantee the right to health technologies. The INTEGRA project (Integration of policies for Health Surveillance, Pharmaceutical Care, Science, Technology, and Innovation in Health) is a partnership among the National Health Council, the National School of Pharmacists, and the Oswaldo Cruz Foundation (Fiocruz), with support from the Pan American Health Organization (PAHO), with the goal of strengthening participation and social engagement in the theme, as well as the integration of health policies and practices within different sectors of society (social movements, health councils, and health professionals), with the various stages related to the access to medicines (research, incorporation, national production, and services) being the main theme in the context of the COVID-19 pandemic. It seeks to offer training for leadership groups in the health regions and activities with a broad national and political scope, and it hopes to establish an intersectorial and integrated network of leaders capable of acting collaboratively to defend the development of science, public policies, national sovereignty, and social control of health.


A 16ª Conferência Nacional de Saúde demonstrou o interesse do controle social em intervir sobre as políticas públicas a fim de garantir o direito às tecnologias de saúde. O projeto Integra - Integração das Políticas de Vigilância em Saúde, Assistência Farmacêutica, Ciência, Tecnologia e Inovação em Saúde -, nasce da parceria entre o Conselho Nacional de Saúde, a Escola Nacional dos Farmacêuticos e a Fundação Oswaldo Cruz (Fiocruz), com apoio da Organização Pan-Americana de Saúde (OPAS) com objetivo de fortalecimento da participação e engajamento social na temática e a integração das políticas e práticas de saúde em diferentes setores da sociedade (movimentos sociais, controle social e profissionais de saúde), tendo as diversas etapas relacionadas ao acesso aos medicamentos (pesquisa, incorporação, produção nacional e serviços) como mote principal, no cenário da pandemia de COVID-19. Oferta-se, neste projeto, capacitação para grupos de lideranças nas regiões de saúde e atividades de grande abrangência nacional e política. Espera-se alcançar o estabelecimento de uma rede intersetorial, integrada de lideranças capazes de atuar colaborativamente para a defesa do desenvolvimento da ciência, das políticas públicas, da soberania nacional e do controle social da saúde.


Subject(s)
COVID-19 , Social Participation , Biomedical Technology , Health Policy , Humans , Pandemics , SARS-CoV-2
4.
Cien Saude Colet ; 26(12): 6105-6116, 2021 Dec.
Article in Portuguese, English | MEDLINE | ID: covidwho-20236335

ABSTRACT

The text presents an updated proposal for a Health Science, Technology and Innovation Policy in Brazil, following the huge political turmoil in the country since 2019 and the COVID-19 pandemic since 2020. The proposal is presented in five sections: Scientific Research; Productive Innovation; Health Technology Assessment and Incorporation; Intellectual Property in Health; New challenges posed by the Pandemic. The authors take part in the Advisory Committee in Science, Technology and Innovation of the Brazilian Association of Collective Health.


O texto contém uma proposta atualizada de política de Ciência, Tecnologia e Inovação em Saúde no Brasil e a pertinência da atualização decorre do desastre nas atividades nesse terreno verificadas no país desde o início do atual governo federal em 2019, bem como dos desafios colocados pela emergência da pandemia COVID-19 desde 2020. Ele está organizado em cinco seções, a saber: Pesquisa em Saúde; Inovação Produtiva; Avaliação e Incorporação de Tecnologias em Saúde; Propriedade Intelectual em Saúde; Novos desafios colocados pela Pandemia. Os autores fazem parte do Comitê de Assessoramento em Ciência, Tecnologia e Inovação da Abrasco.


Subject(s)
COVID-19 , Pandemics , Brazil , Health Policy , Humans , SARS-CoV-2 , Technology
9.
Recenti Prog Med ; 114(6): 327-328, 2023 06.
Article in Italian | MEDLINE | ID: covidwho-20240014

ABSTRACT

The effective use of data in healthcare, and the use of information to support decision-making processes is a key issue. Experiencing the Covid-19 pandemic drove to important developments in a relatively short time. In this context, Cittadinanzattiva, which has been dealing with citizens' rights in the health field for years, is really interested in exploring the boundaries between citizens' right to privacy and the promotion of health as a fundamental human right. New strategies to protect the individual and his dignity should be identified, without hindering the use of data to support health policy. The relationship between health and privacy is a pivotal issue because it involves two of the fundamental rights that are most exposed to the evolution of technology and innovation.


Subject(s)
COVID-19 , Privacy , Humans , Pandemics , Data Management , Health Policy
10.
Lancet Glob Health ; 11(4): e480-e481, 2023 04.
Article in English | MEDLINE | ID: covidwho-20237985
13.
BMJ ; 381: 1232, 2023 05 31.
Article in English | MEDLINE | ID: covidwho-20232056
15.
BMC Public Health ; 23(1): 932, 2023 05 23.
Article in English | MEDLINE | ID: covidwho-20244245

ABSTRACT

BACKGROUND: The success of the COVID-19 vaccination roll-out depended on clear policy communication and guidance to promote and facilitate vaccine uptake. The rapidly evolving pandemic circumstances led to many vaccine policy amendments. The impact of changing policy on effective vaccine communication and its influence in terms of societal response to vaccine promotion are underexplored; this qualitative research addresses that gap within the extant literature. METHODS: Policy communicators and community leaders from urban and rural Ontario participated in semi-structured interviews (N = 29) to explore their experiences of COVID-19 vaccine policy communication. Thematic analysis was used to produce representative themes. RESULTS: Analysis showed rapidly changing policy was a barrier to smooth communication and COVID-19 vaccine roll-out. Continual amendments had unintended consequences, stimulating confusion, disrupting community outreach efforts and interrupting vaccine implementation. Policy changes were most disruptive to logistical planning and community engagement work, including community outreach, communicating eligibility criteria, and providing translated vaccine information to diverse communities. CONCLUSIONS: Vaccine policy changes that allow for prioritized access can have the unintended consequence of limiting communities' access to information that supports decision making. Rapidly evolving circumstances require a balance between adjusting policy and maintaining simple, consistent public health messages that can readily be translated into action. Information access is a factor in health inequality that needs addressing alongside access to vaccines.


Subject(s)
COVID-19 , Health Communication , Humans , Ontario , COVID-19 Vaccines , Health Status Disparities , Health Policy , Qualitative Research
17.
Health Res Policy Syst ; 21(1): 45, 2023 Jun 06.
Article in English | MEDLINE | ID: covidwho-20242042

ABSTRACT

BACKGROUND: Demand for rapid evidence-based syntheses to inform health policy and systems decision-making has increased worldwide, including in low- and middle-income countries (LMICs). To promote use of rapid syntheses in LMICs, the WHO's Alliance for Health Policy and Systems Research (AHPSR) created the Embedding Rapid Reviews in Health Systems Decision-Making (ERA) Initiative. Following a call for proposals, four LMICs were selected (Georgia, India, Malaysia and Zimbabwe) and supported for 1 year to embed rapid response platforms within a public institution with a health policy or systems decision-making mandate. METHODS: While the selected platforms had experience in health policy and systems research and evidence syntheses, platforms were less confident conducting rapid evidence syntheses. A technical assistance centre (TAC) was created from the outset to develop and lead a capacity-strengthening program for rapid syntheses, tailored to the platforms based on their original proposals and needs as assessed in a baseline questionnaire. The program included training in rapid synthesis methods, as well as generating synthesis demand, engaging knowledge users and ensuring knowledge uptake. Modalities included live training webinars, in-country workshops and support through phone, email and an online platform. LMICs provided regular updates on policy-makers' requests and the rapid products provided, as well as barriers, facilitators and impacts. Post-initiative, platforms were surveyed. RESULTS: Platforms provided rapid syntheses across a range of AHPSR themes, and successfully engaged national- and state-level policy-makers. Examples of substantial policy impact were observed, including for COVID-19. Although the post-initiative survey response rate was low, three quarters of those responding felt confident in their ability to conduct a rapid evidence synthesis. Lessons learned coalesced around three themes - the importance of context-specific expertise in conducting reviews, facilitating cross-platform learning, and planning for platform sustainability. CONCLUSIONS: The ERA initiative successfully established rapid response platforms in four LMICs. The short timeframe limited the number of rapid products produced, but there were examples of substantial impact and growing demand. We emphasize that LMICs can and should be involved not only in identifying and articulating needs but as co-designers in their own capacity-strengthening programs. More time is required to assess whether these platforms will be sustained for the long-term.


Subject(s)
COVID-19 , Developing Countries , Humans , Health Policy , Policy Making , Surveys and Questionnaires
18.
East. Mediterr. health j ; 29(4): 232-235, 2023-04.
Article in English | WHOLIS, WHOIRIS | ID: covidwho-2321732
19.
Cien Saude Colet ; 28(5): 1325-1339, 2023 May.
Article in Portuguese, English | MEDLINE | ID: covidwho-2325633

ABSTRACT

The aim of this study was to analyze the organization and development of primary health care and surveillance, including normative frameworks and the implementation of local health actions. Qualitative descriptive multiple-case study involving three municipalities in the state of Bahia. We conducted 75 interviews and a document analysis. The results were categorized into the following two dimensions: approach to the organization of the pandemic response; and development of care and surveillance actions at local level. Municipality 1 was found to have a well-defined concept of the integration of health and surveillance with a view to organizing team work processes. However, the municipality did not strengthen the technical capacity of health districts to support surveillance actions. In M2 and M3, delays in defining PHC as the entry point for the health system and the prioritization of a central telemonitoring service run by the municipal health surveillance department compounded the fragmentation of actions and meant that PHC services played only a limited role in the pandemic response. Clear policy and technical guidelines and adequate structural conditions are vital to ensure the effective reorganization of work processes and foster the development of permanent arrangements that strengthen intersectoral collaboration.


O estudo objetivou analisar a organização e o desenvolvimento das ações de vigilância e atenção na APS, desde o arcabouço normativo até a execução das ações sanitárias nos territórios de abrangência das equipes de saúde. Estudo exploratório, analítico-descritivo, de natureza qualitativa, de casos múltiplos em três municípios-sede de região de saúde na Bahia. Foram feitas 75 entrevistas e análise documental. Os resultados consideraram a lógica de organização tecnológica e o desenvolvimento das ações de atenção e vigilância em saúde pelas equipes no nível local. No caso do M1, constatou-se uma concepção bem definida sobre a integração das ações, com vistas à organização do processo de trabalho das equipes. Contudo, não houve aumento da capacidade técnica dos distritos sanitários para apoiar as ações de vigilância junto às equipes. Em M2 e M3, a demora na definição da APS como porta de entrada e a priorização de serviço central de telemonitoramento realizado pela vigilância municipal reforçou a fragmentação das ações, revelando um baixo protagonismo da APS nas respostas. Diretrizes políticas e técnicas e condições estruturais mostraram-se fundamentais para a reorganização do trabalho, de modo a fomentar arranjos permanentes que promovam condições e incentivem a colaboração intersetorial.


Subject(s)
COVID-19 , Humans , Cities , Brazil/epidemiology , Health Policy , Primary Health Care
20.
Front Public Health ; 11: 1099552, 2023.
Article in English | MEDLINE | ID: covidwho-2326367

ABSTRACT

Introduction: We explored priorities and perspectives on health policy and payer strategies for improving HPV vaccination rates in safety-net settings in the United States. Methods: We conducted qualitative interviews with policy and payer representatives in the greater Los Angeles region and state of New Jersey between December 2020 and January 2022. Practice Change Model domains guided data collection, thematic analysis, and interpretation. Results: Five themes emerged from interviews with 11 policy and 8 payer participants, including: (1) payer representatives not prioritizing HPV vaccination specifically in incentive-driven clinic metrics; (2) policy representatives noting region-specific HPV vaccine policy options; (3) inconsistent motivation across policy/payer groups to improve HPV vaccination; (4) targeting of HPV vaccination in quality improvement initiatives suggested across policy/payer groups; and (5) COVID-19 pandemic viewed as both barrier and opportunity for HPV vaccination improvement across policy/payer groups. Discussion: Our findings indicate opportunities for incorporating policy and payer perspectives into HPV vaccine improvement processes. We identified a need to translate effective policy and payer strategies, such as pay-for-performance programs, to improve HPV vaccination within safety-net settings. COVID-19 vaccination strategies and community efforts create potential policy windows for expanding HPV vaccine awareness and access.


Subject(s)
COVID-19 , Papillomavirus Infections , Papillomavirus Vaccines , Humans , United States , Papillomavirus Infections/prevention & control , Papillomavirus Infections/epidemiology , COVID-19 Vaccines , Pandemics , Reimbursement, Incentive , COVID-19/prevention & control , Vaccination , Health Policy , Papillomavirus Vaccines/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL